166 related articles for article (PubMed ID: 10411322)
1. Should prolactin be reconsidered as a therapeutic target in human breast cancer?
Goffin V; Touraine P; Pichard C; Bernichtein S; Kelly PA
Mol Cell Endocrinol; 1999 May; 151(1-2):79-87. PubMed ID: 10411322
[TBL] [Abstract][Full Text] [Related]
2. Involvement of prolactin in breast cancer: redefining the molecular targets.
Llovera M; Touraine P; Kelly PA; Goffin V
Exp Gerontol; 2000 Feb; 35(1):41-51. PubMed ID: 10705038
[TBL] [Abstract][Full Text] [Related]
3. Prolactin involvement in breast cancer.
Vonderhaar BK
Endocr Relat Cancer; 1999 Sep; 6(3):389-404. PubMed ID: 10516853
[TBL] [Abstract][Full Text] [Related]
4. Prolactin as an autocrine/paracrine factor in breast tissue.
Clevenger CV; Plank TL
J Mammary Gland Biol Neoplasia; 1997 Jan; 2(1):59-68. PubMed ID: 10887520
[TBL] [Abstract][Full Text] [Related]
5. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.
Llovera M; Pichard C; Bernichtein S; Jeay S; Touraine P; Kelly PA; Goffin V
Oncogene; 2000 Sep; 19(41):4695-705. PubMed ID: 11032019
[TBL] [Abstract][Full Text] [Related]
6. Prolactin: the new biology of an old hormone.
Goffin V; Binart N; Touraine P; Kelly PA
Annu Rev Physiol; 2002; 64():47-67. PubMed ID: 11826263
[TBL] [Abstract][Full Text] [Related]
7. Prolactin: the forgotten hormone of human breast cancer.
Vonderhaar BK
Pharmacol Ther; 1998 Aug; 79(2):169-78. PubMed ID: 9749881
[TBL] [Abstract][Full Text] [Related]
8. Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth.
Liby K; Neltner B; Mohamet L; Menchen L; Ben-Jonathan N
Breast Cancer Res Treat; 2003 May; 79(2):241-52. PubMed ID: 12825859
[TBL] [Abstract][Full Text] [Related]
9. Prolactin as an autocrine/paracrine growth factor in human cancer.
Ben-Jonathan N; Liby K; McFarland M; Zinger M
Trends Endocrinol Metab; 2002 Aug; 13(6):245-50. PubMed ID: 12128285
[TBL] [Abstract][Full Text] [Related]
10. The role of prolactin in mammary carcinoma.
Clevenger CV; Furth PA; Hankinson SE; Schuler LA
Endocr Rev; 2003 Feb; 24(1):1-27. PubMed ID: 12588805
[TBL] [Abstract][Full Text] [Related]
11. Development of new prolactin analogs acting as pure prolactin receptor antagonists.
Goffin V; Bernichtein S; Kayser C; Kelly PA
Pituitary; 2003 Sep; 6(2):89-95. PubMed ID: 14703018
[TBL] [Abstract][Full Text] [Related]
12. Local insulin-like growth factor-II mediates prolactin-induced mammary gland development.
Hovey RC; Harris J; Hadsell DL; Lee AV; Ormandy CJ; Vonderhaar BK
Mol Endocrinol; 2003 Mar; 17(3):460-71. PubMed ID: 12554791
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer.
Bonneterre J; Peyrat JP; Beuscart R; Demaille A
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):977-81. PubMed ID: 2285609
[TBL] [Abstract][Full Text] [Related]
14. 16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo.
Faupel-Badger JM; Ginsburg E; Fleming JM; Susser L; Doucet T; Vonderhaar BK
Horm Cancer; 2010 Apr; 1(2):71-9. PubMed ID: 21113329
[TBL] [Abstract][Full Text] [Related]
15. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.
Bole-Feysot C; Goffin V; Edery M; Binart N; Kelly PA
Endocr Rev; 1998 Jun; 19(3):225-68. PubMed ID: 9626554
[TBL] [Abstract][Full Text] [Related]
16. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.
Nouhi Z; Chughtai N; Hartley S; Cocolakis E; Lebrun JJ; Ali S
Cancer Res; 2006 Feb; 66(3):1824-32. PubMed ID: 16452244
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.
Leehy KA; Truong TH; Mauro LJ; Lange CA
J Steroid Biochem Mol Biol; 2018 Feb; 176():88-93. PubMed ID: 28442393
[TBL] [Abstract][Full Text] [Related]
18. Mammary gland development and the prolactin receptor.
Binart N; Ormandy CJ; Kelly PA
Adv Exp Med Biol; 2000; 480():85-92. PubMed ID: 10959413
[TBL] [Abstract][Full Text] [Related]
19. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
Gutzman JH; Miller KK; Schuler LA
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085
[TBL] [Abstract][Full Text] [Related]
20. The many faces of prolactin in breast cancer.
Chen WY
Adv Exp Med Biol; 2015; 846():61-81. PubMed ID: 25472534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
